These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 200039)
1. [Biologic-economic study of processes for cultivating Clostridium perfringens. II. Comparison of the effectiveness of actual and predicted processes for cultivating microorganisms]. Zaporozhtsev LN; Basnak'ian IA; Il'nitskaia EA; Vlasenko AP; Artem'eva TA Zh Mikrobiol Epidemiol Immunobiol; 1977 Oct; (10):37-43. PubMed ID: 200039 [TBL] [Abstract][Full Text] [Related]
2. [Biological-economic study of the Clostridium perfringens cultivation processes. 1. Value of the phasic portrait in the prognosis of the processes of microbial cultivation]. Basnak'ian IA; Zaporozhtsev LN; Gruntovich VS; Mel'nikova VA; Krylov IuM Zh Mikrobiol Epidemiol Immunobiol; 1977 Sep; (9):12-6. PubMed ID: 202118 [No Abstract] [Full Text] [Related]
3. [Analysis and improvement of culture processes of pathogenic microorganisms]. Zaporozhtsev LN Zh Mikrobiol Epidemiol Immunobiol; 1981; (8):19-25. PubMed ID: 6274109 [No Abstract] [Full Text] [Related]
4. [Use of an experimental analytical method for equilibrating nutrient broths for Clostridium perfringens type A growth and toxin formation]. Artemenko VD; Ivanova LG; Nenashev VP; Kuznetsova GI; Ochkina NI Zh Mikrobiol Epidemiol Immunobiol; 1985 Nov; (11):37-41. PubMed ID: 2868592 [TBL] [Abstract][Full Text] [Related]
5. [The use of a cell immobilization technic for the continuous cultivation of toxin-forming anaerobes]. Telishevskaia LIa Zh Mikrobiol Epidemiol Immunobiol; 1995; (6):21-2. PubMed ID: 8553730 [No Abstract] [Full Text] [Related]
6. The effects of probiotic Bacillus coagulans on the cytotoxicity and expression of alpha toxin gene of Clostridium perfringens type A. Kawarizadeh A; Tabatabaei M; Hosseinzadeh S; Farzaneh M; Pourmontaseri M Anaerobe; 2019 Oct; 59():61-67. PubMed ID: 31125604 [TBL] [Abstract][Full Text] [Related]
7. Growth conditions of clostridium perfringens type B for production of toxins used to obtain veterinary vaccines. Viana Brandi I; Domenici Mozzer O; Jorge EV; Vieira Passos FJ; Lopes Passos FM; Cangussu AS; Macedo Sobrinho E Bioprocess Biosyst Eng; 2014 Sep; 37(9):1737-42. PubMed ID: 24573216 [TBL] [Abstract][Full Text] [Related]
8. [Effect of iron on the growth and toxin formation of Clostridium perfringens type A cultures]. Artemenko VD; Kuznetsova GI; Nenashev VP Zh Mikrobiol Epidemiol Immunobiol; 1984 Oct; (10):20-4. PubMed ID: 6098107 [TBL] [Abstract][Full Text] [Related]
9. Dynamics of plc gene transcription and alpha-toxin production during growth of Clostridium perfringens strains with contrasting alpha-toxin production. Abildgaard L; Schramm A; Rudi K; Højberg O Vet Microbiol; 2009 Oct; 139(1-2):202-6. PubMed ID: 19559545 [TBL] [Abstract][Full Text] [Related]
10. [Regulation of the toxin production in Clostridium perfringens]. Shimizu T Nihon Saikingaku Zasshi; 1995 Jul; 50(3):737-44. PubMed ID: 7474345 [No Abstract] [Full Text] [Related]
11. Effect of protease on the production of Clostridium perfringens alpha toxin. Sato H; Yamakawa Y; Ito A; Murata R Jpn J Med Sci Biol; 1977 Feb; 30(1):44-6. PubMed ID: 195109 [No Abstract] [Full Text] [Related]
12. Regulation of Toxin Production in Clostridium perfringens. Ohtani K; Shimizu T Toxins (Basel); 2016 Jul; 8(7):. PubMed ID: 27399773 [TBL] [Abstract][Full Text] [Related]
13. Enhanced production of phospholipase C and perfringolysin O (alpha and theta toxins) in a gatifloxacin-resistant strain of Clostridium perfringens. Rafii F; Park M; Bryant AE; Johnson SJ; Wagner RD Antimicrob Agents Chemother; 2008 Mar; 52(3):895-900. PubMed ID: 18160514 [TBL] [Abstract][Full Text] [Related]
14. [Complementation of theta-and kappa-toxin production between two group mutants of Clostridium perfringens (author's transl)]. Higashi Y Tanpakushitsu Kakusan Koso; 1976 Nov; Suppl():160-3. PubMed ID: 194281 [No Abstract] [Full Text] [Related]
15. Toxigenic characteristics of Clostridium perfringens type C in enterotoxemia of domestic animals. Niilo L Can J Vet Res; 1987 Apr; 51(2):224-8. PubMed ID: 2886206 [TBL] [Abstract][Full Text] [Related]
16. Regulation of extracellular toxin production in Clostridium perfringens. Rood JI; Lyristis M Trends Microbiol; 1995 May; 3(5):192-6. PubMed ID: 7627457 [TBL] [Abstract][Full Text] [Related]
17. [Production, purification and characterization of some Clostridium perfringens toxins]. Capunzo M; Mariano A; Cavallo R G Batteriol Virol Immunol; 1982; 75(1-6):48-61. PubMed ID: 6315516 [TBL] [Abstract][Full Text] [Related]
18. Toxin production by Clostridium perfringens isolated from broiler chickens and capercaillies (Tetrao urogallus) with and without necrotizing enteritis. Hofshagen M; Stenwig H Avian Dis; 1992; 36(4):837-43. PubMed ID: 1485870 [TBL] [Abstract][Full Text] [Related]
19. [Use of molasses and whey in culture media for the development and production of a toxin from Clostridium perfringens type D]. Silva HJ; Giulietti AM; Segovia RF; Ertola RJ Rev Argent Microbiol; 1982; 14(2):85-90. PubMed ID: 6101000 [TBL] [Abstract][Full Text] [Related]